Create
Log in
Enquire now
Viracta Therapeutics
Viral activation therapy
Overview
Structured Data
Issues
Contributors
Access by API
Access by API
Is a
Company
Organization
Board of Directors
Mark Rothera
0
Ivor Royston
0
Thomas E. Darcy
0
Roger Pomerantz
0
Sam Murphy
0
Flavia Borellini
0
Nicole Onetto
0
Stephen Rubino
0
CEO
Mark Rothera
0
CFO
Dan Chevallard
0
CIK Number
1,061,027
0
Legal Name
Viracta Therapeutics, Inc.
0
Company Operating Status
Active
Contact Page URL
viracta.com/contact/
COO
Dan Chevallard
0
Country
United States
0
Crunchbase URL
crunchbase.com/organiz...apeutics
Email Address
info@viracta.com
0
Former CEO
Ivor Royston
0
Full Address
2533 S. Coast Hwy 101, Suite 210, Cardiff, CA 92007, USA
0
Industry
Engineering
Biomedical engineering
Technology
Biology
Biotechnology
Investors
Forward Ventures
Wicklow Capital
Latterell Venture Partners
DeNovo Ventures
NantKwest
IRS Number
943,295,878
0
Latest Funding Round Date
December 2020
Latest Funding Type
Series B
Legal classification
Public company
0
LinkedIn URL
@company/viracta-therapeutics-inc.
Location
California
San Diego
Cardiff-by-the-Sea, Encinitas, California
0
NAICS Code
325,412
0
Number of Employees
28
0
Number of Employees (Ranges)
11 – 50
Phone Number
+18584008470
0
Pitchbook URL
pitchbook.com/profiles...150408-73
Place of Incorporation
Delaware
0
Previous Name
SUNESIS PHARMACEUTICALS INC
0
SIC Code
2,834
0
Exchange
Nasdaq
0
Stock Symbol
VIRX
0
Ticker Symbol
VIRX
0
Total Funding Amount (USD)
83,399,999
Twitter URL
@viractat
Official Website
viracta.com
Find more companies like Viracta Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE